Smith Anglin Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,211
Closed -$259K 220
2025
Q1
$259K Buy
10,211
+2,418
+31% +$63.3K 0.03% 171
2024
Q4
$207K Sell
7,793
-14,728
-65% -$399K 0.02% 201
2024
Q3
$652K Buy
22,521
+495
+2% +$14.4K 0.06% 99
2024
Q2
$616K Buy
22,026
+1,472
+7% +$40.5K 0.06% 90
2024
Q1
$570K Buy
20,554
+10,716
+109% +$297K 0.06% 104
2023
Q4
$283K Sell
9,838
-2,607
-21% -$78.8K 0.03% 140
2023
Q3
$413K Buy
12,445
+136
+1% +$4.81K 0.05% 107
2023
Q2
$451K Buy
12,309
+3,343
+37% +$130K 0.05% 103
2023
Q1
$366K Buy
8,966
+36
+0.4% +$1.55K 0.05% 108
2022
Q4
$458K Sell
8,930
-582
-6% -$27.9K 0.09% 87
2022
Q3
$416K Sell
9,512
-24
-0.3% -$1.17K 0.09% 86
2022
Q2
$500K Buy
9,536
+28
+0.3% +$1.43K 0.15% 72
2022
Q1
$492K Sell
9,508
-562
-6% -$29.2K 0.11% 75
2021
Q4
$595K Buy
10,070
+4,794
+91% +$238K 0.1% 80
2021
Q3
$227K Sell
5,276
-364
-6% -$16.1K 0.04% 127
2021
Q2
$221K Buy
+5,640
New +$219K 0.04% 133
2021
Q1
Sell
-6,193
Closed -$228K 143
2020
Q4
$228K Buy
+6,193
New +$227K 0.04% 122

Other funds holding PFE

Smith Anglin Financial's PFE Position: Q2 2025 in Review

Smith Anglin Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 10,211 shares — an estimated $259K sold.

Smith Anglin Financial first reported a position in PFE in Q4 2020 and held it in 17 quarters. The position peaked at $652K in Q3 2024. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Smith Anglin Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Smith Anglin Financial sold 10,211 Pfizer shares in Q2 2025, an estimated $259K.
  • Smith Anglin Financial first reported a position in Pfizer in Q4 2020 and held it in 17 quarters.
  • Smith Anglin Financial's Pfizer position peaked at $652K in Q3 2024.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Smith Anglin Financial's 13F filing for Q2 2025, filed 17 Jul 2025.